Health care stocks were mixed premarket Thursday, with The Health Care Select Sector SPDR Fund (XLV) marginally higher and the iShares Biotechnology ETF (IBB) down 0.4%.
Nano-X Imaging (NNOX) shares were up past 15% after the company said it received 510(k) clearance from the US Food and Drug Administration for its Nanox.ARC stationary X-ray system.
Patterson Companies (PDCO) stock was over 7% higher after the company posted an increase in its fiscal Q2 net sales.
Mesoblast (MESO) shares were down more than 4% even after the company said the US Food and Drug Administration granted the company's second-generation cell therapy, Revascor, a regenerative medicine advanced therapy designation.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。